(HealthDay News) — A chocolate male enhancement product is being pulled from store shelves after federal health officials found it contains a hidden prescription drug. The company — USALESS.COM, based ...
In the absence of trials, a post hoc analysis compared stereotactic body radiotherapy (SBRT) and high-dose-rate brachytherapy (HDR-BT) in intermediate-risk prostate cancer.
(HealthDay News) — Adult patients with cancer who experience a new-onset mental health disorder (MHD) have an increased risk for death, according to a study published online Feb. 23 in Cancer.
(HealthDay News) — Metabolic dysfunction, rather than steatotic liver disease (SLD), seems to be the main driver of chronic kidney disease (CKD) risk, according to research published online Feb. 23 in ...
In this observational study, researchers aimed to assess real-world use of relugolix among prostate cancer patients.
In this study, researchers sought to determine whether HER2-targeted therapies, including disitamab vedotin, have clinical utility in pretreated, HER2-positive, locally advanced unresectable or ...
A randomized trial of hospitalized patients with moderate hyponatremia compared targeted sodium correction versus routine care on mortality and rehospitalization rates.
MARCAP investigators conducted the first individual patient data meta-analysis of randomized trials (POSEIDON) evaluating the use and duration hormone therapy with postoperative radiation therapy in ...
(HealthDay News) — Primary care use among patients requiring hemodialysis is associated with lower mortality, according to a study published online Feb. 2 in Kidney Medicine.
Age, spinal cord injury severity, C-reactive protein levels, urination modes, and pain severity all significantly impact incidence.
In prostate cancer, prostate brachytherapy boost improves biochemical failure at 10 years but does not prolong long-term OS compared to EBRT boost.
(HealthDay News) — Counties located closer to operational nuclear power plants have higher cancer mortality rates, according to a study published online Feb. 23 in Nature Communications.